
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
TCS has partnered with Anthropic to scale enterprise AI, rolling out Claude to 50,000 employees and jointly targeting regulated sectors with compliance-focused solutions.
MTAR Technologies shares fell up to 12% as profit-booking and a pause in a US data-centre project raised worries around key client Bloom Energy.
Indian pharma and CRDMO stocks rose after the Pentagon flagged WuXi AppTec, while Jefferies reiterated buy calls on Sai Life Sciences and Divi’s Laboratories with higher targets.
Social media traders are tracking Sensex expiry call buying via OI, PCR and Max Pain, focusing on shifting support-resistance zones and strict risk rules for weekly theta decay.
Bharat Forge says it is working with three of the world’s five biggest chipmakers to supply lithography machine parts, as India expands incentives under ISM 2.0.
DOMS Industries signed an asset purchase agreement to acquire select Reynolds brand assets for ₹30.71 crore (US$3.7 million), pushing the stock up about 6% in trade.
MTAR Technologies slid after reports that Crusoe paused a 1.8-GW Wyoming data-centre campus expected to use Bloom Energy fuel cells, denting sentiment around Bloom’s pipeline.
Alembic Pharmaceuticals reported multiple USFDA actions, including tentative approvals for key oncology generics and final approvals for diabetes and injectable oncology products, with some launches tied to litigation outcomes.
GIFT Nifty traded near 23,169 early Wednesday, pointing to a lower start for Sensex and Nifty amid US-Iran tensions, higher crude, weak Asia, and FII selling.
TCS has signed a global strategic partnership with Anthropic, rolling out Claude to 50,000 employees and jointly taking AI offerings to heavily regulated industries.
Indian sugar stocks gained on June 11 after the government exempted petrol with 22% to 30% ethanol from excise duty, supporting higher ethanol blending demand.
PPAP Automotive shares rose up to 18% after a technology partnership with France’s Hutchinson, giving an exclusive India licence to make advanced body sealing systems.
AstraZeneca Pharma India said CDSCO has approved Enhertu for an additional indication, expanding its use in advanced HER2-positive cancers and widening treatment options for oncologists.
Corporate India reported its fastest revenue growth in three years in Q4FY26, with profits up 15.1% YoY and margins hitting a multi-quarter high.
Brokerages remain positive on Honasa Consumer, citing premiumisation, offline expansion and margin improvement, while noting competition and execution risks amid mixed valuation views.
Indian IT stocks stayed under pressure across multiple sessions as Anthropic’s new Claude tools and global tech weakness raised fresh concerns about disruption to outsourcing-led revenue models.